Inc. (CIIX) Prioritizing Profit for 2020, Increasing Margin Sales, Cutting Costs

January 6, 2020 12:33:35
  • CIIX CEO speaks to attaining profitability in 2020 as company grows revenue
  • Subsidiary CBD Biotech and CBD cosmetics instrumental in driving CIIX’s growth
  • CIIX leadership focusing on cost cutting, maintaining profitability, and increased revenue with high margin product sales Inc. (OTCQB: CIIX) CEO Warren Wang spoke optimistically about his company’s growth potential in a recent MoneyTV interview with host Donald Baillargeon. Wang said the company would focus in 2020 on building more revenue from high margin products and cutting costs to achieve profitability. He also emphasized the important role subsidiary CBD Biotech and CBD-infused cosmetics products would play in China.

He cited the high gross margins of CBD cosmetics for the company and said the firm would work to bring more of that profitability down to the bottom line through lower costs and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.